Richie Capital on Viemed (VMD): “Hurdles will Subside, VMD will be Back on Track in 2021”

Richie Capital Group LLC, an equity-focused investment management firm, published its fourth quarter 2020 investor letter – a copy of which can be downloaded here. A return of -11.5% was recorded by the fund’s Long Short Portfolio in the fourth quarter of 2020, below its Russell 3000 benchmark, and S&P 500 index that delivered a 14.7% and 11.7% return respectively in the same period. Meanwhile, Richie Capital Group’s Long Only Portfolio delivered a 16.9% return in the past quarter. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.

Richie Capital Group, in their Q4 2020 investor letter, mentioned Viemed Healthcare, Inc. (NASDAQ: VMD) and emphasized their views on the company. Viemed Healthcare, Inc. is a Lafayette, Louisiana-based equipment and home therapy provider that currently has a $378.8 billion market capitalization. Since the beginning of the year, VMD delivered a 23.45% return, impressively extending its 12-month gains to 109.63%. As of March 29, 2021, the stock closed at $9.58 per share.

Here is what Richie Capital Group has to say about Viemed Healthcare, Inc. in their Q4 2020 investor letter:

Viemed Healthcare (VMD – Down 10.2%) – The respiratory healthcare services company was a detractor for the second quarter in a row. The pandemic has increased overall awareness of acute lung diseases and has allowed management to develop new customer relationships by providing much needed ventilators during the height of the crisis. However, hospital restrictions have hindered the company’s ability to access hospitals and clinics. Physicians have diverted their focus from addressing COPD patients to the more immediate needs of Covid. Our investment thesis has not changed. We expect these hurdles to subside, placing VMD back on track in 2021.”

Romaset/Shutterstock.com

Our calculations show that Viemed Healthcare, Inc. (NASDAQ: VMD) does not belong in our list of the 30 Most Popular Stocks Among Hedge Funds. As of the end of the fourth quarter of 2020, Viemed Healthcare, Inc. was in 12 hedge fund portfolios, compared to 14 funds in the third quarter. VMD delivered a -4.82% return in the past 3 months.